Geode Capital Management
INDV icon

Geode Capital Management’s Indivior Pharmaceuticals INDV Stock Holding History

Geode Capital Management’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$130M Buy
3,159,866
+234,178
+8% +$8.49M 0.01% 1026
2026
Q1 		$89.2M Buy
2,925,688
+87,864
+3% +$2.9M 0.01% 1159
2025
Q4 		$102M Sell
2,837,824
-18,607
-0.7% -$568K 0.01% 1067
2025
Q3 		$68.9M Buy
2,856,431
+1,279,516
+81% +$26.8M ﹤0.01% 1281
2025
Q2 		$23.2M Buy
1,576,915
+1,447,939
+1,123% +$16.9M ﹤0.01% 1885
2025
Q1 		$1.23M Buy
128,976
+92
+0.1% +$967 ﹤0.01% 3234
2024
Q4 		$1.6M Sell
128,884
-3,355
-3% -$34.5K ﹤0.01% 3206
2024
Q3 		$1.29M Buy
132,239
+9,500
+8% +$111K ﹤0.01% 3265
2024
Q2 		$1.98M Buy
122,739
+8,113
+7% +$146K ﹤0.01% 3131
2024
Q1 		$2.46M Buy
114,626
+6,594
+6% +$124K ﹤0.01% 3036
2023
Q4 		$1.65M Buy
108,032
+1,137
+1% +$20.2K ﹤0.01% 3172
2023
Q3 		$2.41M Buy
106,895
+2,291
+2% +$52.2K ﹤0.01% 3009
2023
Q2 		$2.51M Buy
+104,604
New +$2.4M ﹤0.01% 3039

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return

Geode Capital Management's INDV Position: Q2 2026 in Review

Geode Capital Management increased its Indivior Pharmaceuticals (INDV) stake by 8% in Q2 2026, buying an estimated $8.49M and bringing the position to 3,159,866 shares worth $130M. The position accounts for 0.01% of the portfolio, ranked #1026.

Geode Capital Management first reported a position in INDV in Q2 2023 and has held it in 13 quarters since. 315 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • Geode Capital Management held 3,159,866 shares of Indivior Pharmaceuticals worth $130M as of Q2 2026.
  • Geode Capital Management bought 234,178 Indivior Pharmaceuticals shares in Q2 2026, an estimated $8.49M.
  • Indivior Pharmaceuticals made up 0.01% of Geode Capital Management's portfolio in Q2 2026, its #1026 holding.
  • Geode Capital Management first reported a position in Indivior Pharmaceuticals in Q2 2023 and has held it in 13 quarters since.
  • 315 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.